Prostate cancer
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Localized prostate cancer diagnosed by pathology (cT1-2N0M0) ; 2. Age =22 points and no history of erectile dysfunction treatment; 5. PSA4-20ng\/ml, Gleason score <=4+3; 6. Patients agreed to be random and signed informed consent form.
Exclusion criteria
Exclusion criteria: 1. Urinary incontinence (ICI-Q-SF=6) or neurogenic bladder before operation. 2. History of pelvic radiotherapy, chemotherapy, surgery and endocrine therapy. 3. Imaging suspected lymph node metastasis or bone metastasis. 4. Severe cardiopulmonary disease can not tolerate surgery. 5. Patients who the researchers think are not suitable for this clinical trial.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Immediate urinary control recovery rate;Short-term (within 3 months) urinary control recovery rate;Progress in restoring sexual function within a short period (3 months).; | — |
Secondary
| Measure | Time frame |
|---|---|
| Perioperative safety index;Tumor control effect; | — |
Countries
China
Contacts
Chinese PLA General Hospital